Abnormalities in parylation can contribute to cancer development and progression. Overactive PARP enzymes can promote tumorigenesis by aiding the repair of damaged DNA, allowing cancer cells to survive despite genomic instability. Conversely, impaired PARP activity can lead to unchecked DNA damage, fostering mutations that drive cancer.
